MarketReportsOnline.com adds "Global Breast Cancer Market: Industry Analysis & Outlook (2018-2022)" report to its research store.

Pune, India -- (SBWire) -- 04/03/2018 --'Breast cancer' defines a malignant tumor that has developed from cells in the breast. Some breast cancers are called in situ as they are confined within the ducts (ductal carcinoma in situ or DCIS) or lobules (lobular carcinoma in situ or LCIS) where they originated.

Complete report on Breast Cancer Market spread across 82 pages with providing 4 company profiles, 7 tables and 45 charts is now available at http://www.marketreportsonline.com/740652.html.

Although, less commonly, breast cancer can also instigate in the stromal tissues, which includes the fatty and fibrous connective tissues of the breast. In the early stages, breast cancer may not cause any symptoms. A lump may be too small to feel or to cause any unusual changes that could be noticed on own. Typically, an abnormal area shows up on a screening mammogram which leads to further testing. Several risk factors including smoking and alcohol consumption, exposure to estrogen, gender, age, family history and personal history are linked to the growth of breast cancer.

Purchase a copy of this "Global Breast Cancer Market" report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=740652.

The global breast cancer market is likely to grow strongly in the coming years driven by rising healthcare expenditure, rising diabetic and obese population, increasing consumption of alcohol and tobacco and rising female population above 65 years of age. Key trends of the market includes rising development of PARP inhibitors, increasing adoption of minimally invasive procedures and rising awareness programs and research grants. However, growth of the market can be hindered by several factors including financial burden of breast cancer, drug development challenges in developing countries, long term side effects of drugs.

The report "Global Breast Cancer Market: Industry Analysis & Outlook (2018-2022)" provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the US, Europe and APAC regions along with the global breast cancer market. The report profiles the key players of the market including Johnson & Johnson, AbbVie, AstraZeneca and Roche

Major Points from Table of Contents:

1. Introduction
1.1 Breast Cancer
1.2 Types
1.3 Stages
1.4 Risk Factors
1.4 Symptoms & Diagnosis
1.5 Treatment

2. Global Breast Cancer Market
2.1 Global Breast Cancer Market by Value
2.2 Global Breast Cancer Market Forecast by Value
2.3 Global Breast Cancer Market by Region
2.4 Global Breast Cancer Drug Development by Stages

3. Regional Breast Cancer Market Analysis
3.1 The U.S.
3.2 Europe
3.3 APAC

4. Market Dynamics
4.1 Growth Drivers
4.2 Key Trends & Developments
4.3 Challenges

5. Competition
5.1 Global Market
5.1.1 Revenue Comparison by Company
5.1.2 R&D Expenditure Comparison by Company
5.1.3 Market Cap Comparison by Company

6. Company Profiles

Browse All Latest Pharmaceuticals Market Research Reports at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Market Reports Online
Market Reports Online is a comprehensive online library of more than 100,000 reports, in-depth market research studies on thousands of micro markets and a range of industries. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. We offer online and offline support services to ensure your research requirements are met on time.

Contact Us:
Hrishikesh Patwardhan
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Maharashtra, India.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com